首页> 外文期刊>Frontiers in Chemistry >α-Glucosidase Inhibitors from the Coral-Associated Fungus Aspergillus terreus
【24h】

α-Glucosidase Inhibitors from the Coral-Associated Fungus Aspergillus terreus

机译:珊瑚相关真菌曲霉曲霉的α-葡萄糖苷酶抑制剂

获取原文
           

摘要

Nine novel butenolide derivatives, including four pairs of enantiomers, named (±)-asperteretones A–D (1a/1b–4a/4b), and a racemate, named asperteretone E (5), were isolated and identified from the coral-associated fungus Aspergillus terreus. All the structures were established based on extensive spectroscopic analyses, including HRESIMS and NMR data. The chiral chromatography analyses allowed the separation of (±)-asperteretones A–D, whose absolute configurations were further confirmed by experimental and calculated electronic circular dichroism (ECD) analysis. Structurally, compounds 2–5 represented the first examples of prenylated γ-butenolides bearing 2-phenyl-3-benzyl-4H-furan-1-one motifs, and their crucial biogenetically related metabolite, compound 1, was uniquely defined by an unexpected cleavage of oxygen bridge between C-1 and C-4. Importantly, (±)-asperteretal D and (4S)-4-decarboxylflavipesolide C were revised to (±)-asperteretones B (2a/2b) and D (4), respectively. Additionally, compounds 1a/1b–4a/4b and 5 were evaluated for the α-glucosidase inhibitory activity, and all these compounds exhibited potent inhibitory potency against α-glucosidase, with IC50 values ranging from 15.7 ± 1.1 to 53.1 ± 1.4 μM, which was much lower than that of the positive control acarbose (IC50 = 154.7 ± 8.1 μM), endowing them as promising leading molecules for the discovery of new α-glucosidase inhibitors for type-2 diabetes mellitus treatment.
机译:从与珊瑚有关的珊瑚中分离并鉴定了九种新颖的丁烯内酯衍生物,包括四对对映异构体,分别命名为(±)-萜烯酮A–D(1a / 1b–4a / 4b)和消旋体,命名为Asperteretone E(5)。真菌曲霉。所有结构都是基于广泛的光谱分析建立的,包括HRESIMS和NMR数据。通过手性色谱分析可以分离出(±)-萜烯酮AD,其绝对构型已通过实验和计算的电子圆二色性(ECD)分析得到了进一步证实。在结构上,化合物2–5代表带有2-苯基-3-苄基-4H-呋喃-1-酮基序的烯丙基化的γ-丁烯化物的第一个例子,其关键的生物遗传相关代谢物化合物1通过意外裂解而唯一定义。 C-1和C-4之间的氧桥重要的是,将(±)-萜烯D和(4S)-4-脱羧基尿嘧啶固体C分别修改为(±)-萜烯二酮B(2a / 2b)和D(4)。此外,还对化合物1a / 1b–4a / 4b和5的α-葡萄糖苷酶抑制活性进行了评估,所有这些化合物均表现出对α-葡萄糖苷酶的有效抑制作用,IC50值范围为15.7±1.1至53.1±1.4μM。远低于阳性对照的阿卡波糖(IC50 = 154.7±8.1μM),使它们成为发现用于治疗2型糖尿病的新型α-葡萄糖苷酶抑制剂的有前途的领先分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号